{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,15]],"date-time":"2026-11-15T01:46:08Z","timestamp":1794707168153,"version":"4.9.1"},"reference-count":49,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Neuropharmacology"],"published-print":{"date-parts":[[2026,2]]},"DOI":"10.1016\/j.neuropharm.2025.110729","type":"journal-article","created":{"date-parts":[[2025,10,24]],"date-time":"2025-10-24T09:48:29Z","timestamp":1761299309000},"page":"110729","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"special_numbering":"C","title":["Parthenolide attenuates neuroinflammation by targeting NLRP3 inflammasome &amp; mitochondrial dysfunction in experimental diabetic neuropathy"],"prefix":"10.1016","volume":"283","author":[{"given":"Lokesh","family":"Sharan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anubroto","family":"Pal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S Sarath","family":"Babu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rachit","family":"Jain","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sugato","family":"Banerjee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6659-4751","authenticated-orcid":false,"given":"Ashutosh","family":"Kumar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.neuropharm.2025.110729_bib1","doi-asserted-by":"crossref","first-page":"654","DOI":"10.1016\/j.expneurol.2014.08.017","article-title":"Matrix metalloproteinase-2 is downregulated in sciatic nerve by streptozotocin induced diabetes and\/or treatment with minocycline: implications for nerve regeneration","volume":"261","author":"Ali","year":"2014","journal-title":"Exp. Neurol."},{"issue":"16","key":"10.1016\/j.neuropharm.2025.110729_bib2","doi-asserted-by":"crossref","first-page":"7574","DOI":"10.1080\/07391102.2021.1900916","article-title":"Methoxylated flavonols from Vellozia dasypus Seub ethyl acetate active myeloperoxidase extract: in vitro and in silico assays","volume":"40","author":"Almeida","year":"2022","journal-title":"J. Biomol. Struct. Dyn."},{"issue":"3","key":"10.1016\/j.neuropharm.2025.110729_bib3","doi-asserted-by":"crossref","DOI":"10.1111\/jpi.12393","article-title":"Melatonin prevents mitochondrial dysfunction and promotes neuroprotection by inducing autophagy during oxaliplatin\u2010evoked peripheral neuropathy","volume":"62","author":"Areti","year":"2017","journal-title":"J. Pineal Res."},{"issue":"8","key":"10.1016\/j.neuropharm.2025.110729_bib4","doi-asserted-by":"crossref","first-page":"1731","DOI":"10.1080\/1028415X.2021.1892985","article-title":"Carvacrol abates NLRP3 inflammasome activation by augmenting Keap1\/Nrf-2\/p62 directed autophagy and mitochondrial quality control in neuropathic pain","volume":"25","author":"Arruri","year":"2022","journal-title":"Nutr. Neurosci."},{"issue":"2","key":"10.1016\/j.neuropharm.2025.110729_bib5","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1002\/biof.1397","article-title":"Morin exerts neuroprotection via attenuation of ROS induced oxidative damage and neuroinflammation in experimental diabetic neuropathy","volume":"44","author":"Bachewal","year":"2018","journal-title":"Biofactors"},{"key":"10.1016\/j.neuropharm.2025.110729_bib6","doi-asserted-by":"crossref","DOI":"10.1016\/j.phyplu.2023.100488","article-title":"The effect of natural products on inflammatory cytokines production and secretion","author":"Barakat","year":"2023","journal-title":"Phytomed. Plus"},{"issue":"19","key":"10.1016\/j.neuropharm.2025.110729_bib7","doi-asserted-by":"crossref","DOI":"10.3390\/ijms221910835","article-title":"Inflammatory mechanisms in the pathophysiology of diabetic peripheral neuropathy (DN)\u2014New aspects","volume":"22","author":"Baum","year":"2021","journal-title":"Int. J. Mol. Sci."},{"issue":"5","key":"10.1016\/j.neuropharm.2025.110729_bib8","doi-asserted-by":"crossref","first-page":"1066","DOI":"10.1016\/j.bbadis.2016.11.010","article-title":"Mitochondrial dysfunction and oxidative stress in metabolic disorders\u2014A step towards mitochondria based therapeutic strategies","volume":"1863","author":"Bhatti","year":"2017","journal-title":"Biochim. Biophys. Acta, Mol. Basis Dis."},{"key":"10.1016\/j.neuropharm.2025.110729_bib9","doi-asserted-by":"crossref","first-page":"1563","DOI":"10.1007\/s10571-020-00923-1","article-title":"SIRT1 activation by polydatin alleviates oxidative damage and elevates mitochondrial biogenesis in experimental diabetic neuropathy","volume":"41","author":"Bheereddy","year":"2021","journal-title":"Cell. Mol. Neurobiol."},{"issue":"1","key":"10.1016\/j.neuropharm.2025.110729_bib10","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/cddiscovery.2017.78","article-title":"Parthenolide prevents resistance of MDA-MB231 cells to doxorubicin and mitoxantrone: the role of Nrf2","volume":"3","author":"Carlisi","year":"2017","journal-title":"Cell Death Discov."},{"issue":"6","key":"10.1016\/j.neuropharm.2025.110729_bib11","doi-asserted-by":"crossref","first-page":"608","DOI":"10.3390\/biomedicines9060608","article-title":"Ammonium glycyrrhizinate prevents apoptosis and mitochondrial dysfunction induced by high glucose in SH-SY5Y cell line and counteracts neuropathic pain in streptozotocin-induced diabetic mice","volume":"9","author":"Ciarlo","year":"2021","journal-title":"Biomedicines"},{"issue":"24","key":"10.1016\/j.neuropharm.2025.110729_bib12","doi-asserted-by":"crossref","DOI":"10.1016\/j.jmb.2021.167309","article-title":"Crystal structure of NLRP3 NACHT domain with an inhibitor defines mechanism of inflammasome inhibition","volume":"433","author":"Dekker","year":"2021","journal-title":"J. Mol. Biol."},{"key":"10.1016\/j.neuropharm.2025.110729_bib13","doi-asserted-by":"crossref","DOI":"10.1016\/j.intimp.2021.108397","article-title":"Probucol attenuates NF-\u03baB\/NLRP3 signalling and augments Nrf-2 mediated antioxidant defence in nerve injury induced neuropathic pain","volume":"102","author":"Derangula","year":"2022","journal-title":"Int. Immunopharmacol."},{"key":"10.1016\/j.neuropharm.2025.110729_bib14","doi-asserted-by":"crossref","first-page":"284","DOI":"10.3389\/fnmol.2017.00284","article-title":"Methods used to evaluate pain behaviors in rodents","volume":"10","author":"Deuis","year":"2017","journal-title":"Front. Mol. Neurosci."},{"key":"10.1016\/j.neuropharm.2025.110729_bib15","doi-asserted-by":"crossref","DOI":"10.1016\/j.intimp.2022.108913","article-title":"Parthenolide ameliorates neurological deficits and neuroinflammation in mice with traumatic brain injury by suppressing STAT3\/NF-\u03baB and inflammasome activation","volume":"108","author":"Ding","year":"2022","journal-title":"Int. Immunopharmacol."},{"issue":"1","key":"10.1016\/j.neuropharm.2025.110729_bib16","article-title":"Parthenolide is neuroprotective in rat experimental stroke model: downregulating NF\u2010\u03baB, phospho\u2010p38MAPK, and caspase\u20101 and ameliorating BBB permeability","volume":"2013","author":"Dong","year":"2013","journal-title":"Mediat. Inflamm."},{"issue":"1","key":"10.1016\/j.neuropharm.2025.110729_bib17","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/0003-2697(86)90061-8","article-title":"Evaluation of the micromethod for determination of glutathione using enzymatic cycling and Ellman&39;s reagent","volume":"153","author":"Eyer","year":"1986","journal-title":"Anal. Biochem."},{"key":"10.1016\/j.neuropharm.2025.110729_bib18","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12974-018-1282-6","article-title":"Mitochondrial dysfunction induces NLRP3 inflammasome activation during cerebral ischemia\/reperfusion injury","volume":"15","author":"Gong","year":"2018","journal-title":"J. Neuroinflammation"},{"issue":"12","key":"10.1016\/j.neuropharm.2025.110729_bib19","doi-asserted-by":"crossref","first-page":"1012","DOI":"10.1016\/j.tibs.2016.09.002","article-title":"Mechanism and regulation of NLRP3 inflammasome activation","volume":"41","author":"He","year":"2016","journal-title":"Trends Biochem. Sci."},{"key":"10.1016\/j.neuropharm.2025.110729_bib20","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1016\/j.neuro.2021.10.007","article-title":"Resveratrol prevents haloperidol-induced mitochondria dysfunction through the induction of autophagy in SH-SY5Y cells","volume":"87","author":"Hu","year":"2021","journal-title":"Neurotoxicology"},{"issue":"7","key":"10.1016\/j.neuropharm.2025.110729_bib21","doi-asserted-by":"crossref","first-page":"4334","DOI":"10.1007\/s12035-022-02858-8","article-title":"Neuroprotective effect of baicalein against oxaliplatin-induced peripheral neuropathy: impact on oxidative stress, neuro-inflammation and WNT\/\u03b2-Catenin signaling","volume":"59","author":"Jugait","year":"2022","journal-title":"Mol. Neurobiol."},{"key":"10.1016\/j.neuropharm.2025.110729_bib22","doi-asserted-by":"crossref","first-page":"3616","DOI":"10.1007\/s12035-020-01989-0","article-title":"Bardoxolone methyl ameliorates hyperglycemia induced mitochondrial dysfunction by activating the keap1-Nrf2-ARE pathway in experimental diabetic neuropathy","volume":"57","author":"Kalvala","year":"2020","journal-title":"Mol. Neurobiol."},{"key":"10.1016\/j.neuropharm.2025.110729_bib23","doi-asserted-by":"crossref","first-page":"1627","DOI":"10.1007\/s43440-020-00147-6","article-title":"Chronic hyperglycemia impairs mitochondrial unfolded protein response and precipitates proteotoxicity in experimental diabetic neuropathy: focus on LonP1 mediated mitochondrial regulation","volume":"72","author":"Kalvala","year":"2020","journal-title":"Pharmacol. Rep."},{"key":"10.1016\/j.neuropharm.2025.110729_bib24","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1007\/s12017-016-8434-6","article-title":"Parthenolide, an NF-\u03baB inhibitor ameliorates diabetes-induced behavioural deficit, neurotransmitter imbalance and neuroinflammation in type 2 diabetes rat model","volume":"19","author":"Khare","year":"2017","journal-title":"NeuroMolecular Med."},{"key":"10.1016\/j.neuropharm.2025.110729_bib25","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejphar.2022.175300","article-title":"NLRP3 inflammasomes: a potential target to improve mitochondrial biogenesis in parkinson&39; s disease","volume":"934","author":"Khot","year":"2022","journal-title":"Eur. J. Pharmacol."},{"issue":"10","key":"10.1016\/j.neuropharm.2025.110729_bib26","doi-asserted-by":"crossref","first-page":"1065","DOI":"10.1080\/10715762.2016.1210141","article-title":"Mitochondrial dynamics altered by oxidative stress in cancer","volume":"50","author":"Kim","year":"2016","journal-title":"Free Radic. Res."},{"key":"10.1016\/j.neuropharm.2025.110729_bib27","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1016\/j.lfs.2016.02.085","article-title":"PARP inhibition attenuates neuroinflammation and oxidative stress in chronic constriction injury induced peripheral neuropathy","volume":"150","author":"Komirishetty","year":"2016","journal-title":"Life Sci."},{"issue":"13","key":"10.1016\/j.neuropharm.2025.110729_bib28","doi-asserted-by":"crossref","first-page":"1236","DOI":"10.1016\/j.lfs.2006.12.036","article-title":"Effects of resveratrol on nerve functions, oxidative stress and DNA fragmentation in experimental diabetic neuropathy","volume":"80","author":"Kumar","year":"2007","journal-title":"Life Sci."},{"issue":"5","key":"10.1016\/j.neuropharm.2025.110729_bib29","doi-asserted-by":"crossref","first-page":"1158","DOI":"10.1016\/j.biochi.2012.01.023","article-title":"Suppression of NF-\u03baB and NF-\u03baB regulated oxidative stress and neuroinflammation by BAY 11-7082 (I\u03baB phosphorylation inhibitor) in experimental diabetic neuropathy","volume":"94","author":"Kumar","year":"2012","journal-title":"Biochimie"},{"issue":"4","key":"10.1016\/j.neuropharm.2025.110729_bib30","doi-asserted-by":"crossref","first-page":"822","DOI":"10.1016\/j.biocel.2004.09.010","article-title":"Mitochondrial biogenesis and mitochondrial DNA maintenance of mammalian cells under oxidative stress","volume":"37","author":"Lee","year":"2005","journal-title":"Int. J. Biochem. Cell Biol."},{"issue":"2","key":"10.1016\/j.neuropharm.2025.110729_bib31","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1007\/s00705-022-05626-0","article-title":"Parthenolide inhibits proliferation of cells infected with Kaposi's sarcoma- associated herpesvirus by suppression of the NF-\u03baB signaling pathway","volume":"168","author":"Li","year":"2023","journal-title":"Arch. Virol."},{"issue":"12","key":"10.1016\/j.neuropharm.2025.110729_bib32","doi-asserted-by":"crossref","first-page":"1221","DOI":"10.3390\/ph14121221","article-title":"Contribution of mitochondrial dysfunction combined with NLRP3 inflammasome activation in selected neurodegenerative diseases","volume":"14","author":"Litwiniuk","year":"2021","journal-title":"Pharmaceuticals"},{"key":"10.1016\/j.neuropharm.2025.110729_bib33","doi-asserted-by":"crossref","DOI":"10.1016\/j.biocel.2021.106013","article-title":"Mitochondrial dysfunction as a driver of NLRP3 inflammasome activation and its modulation through mitophagy for potential therapeutics","volume":"136","author":"Mishra","year":"2021","journal-title":"Int. J. Biochem. Cell Biol."},{"issue":"1\u20132","key":"10.1016\/j.neuropharm.2025.110729_bib34","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1016\/0304-3940(94)90042-6","article-title":"A behavioral model for peripheral neuropathy produced in rat's tail by inferior caudal trunk injury","volume":"177","author":"Na","year":"1994","journal-title":"Neurosci. Lett."},{"issue":"1","key":"10.1016\/j.neuropharm.2025.110729_bib35","doi-asserted-by":"crossref","first-page":"31","DOI":"10.2174\/1573399817666210309104203","article-title":"Diabetic complications: an update on pathobiology and therapeutic strategies","volume":"18","author":"Nellaiappan","year":"2022","journal-title":"Curr. Diabetes Rev."},{"issue":"2","key":"10.1016\/j.neuropharm.2025.110729_bib36","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1016\/0003-2697(79)90738-3","article-title":"Assay for lipid peroxides in animal tissues by thiobarbituric acid reaction","volume":"95","author":"Ohkawa","year":"1979","journal-title":"Anal. Biochem."},{"issue":"1","key":"10.1016\/j.neuropharm.2025.110729_bib37","doi-asserted-by":"crossref","DOI":"10.1155\/2020\/8297984","article-title":"Neuroprotective effect of syringic acid by modulation of oxidative stress and mitochondrial mass in diabetic rats","volume":"2020","author":"Rashedinia","year":"2020","journal-title":"BioMed Res. Int."},{"issue":"3","key":"10.1016\/j.neuropharm.2025.110729_bib38","doi-asserted-by":"crossref","first-page":"230","DOI":"10.3390\/jpm11030230","article-title":"Differences and Similarities in Neuropathy in Type 1 and 2 diabetes: a Systematic Review","volume":"11","author":"Sempere-Bigorra","year":"2021","journal-title":"J. Personalized Med."},{"key":"10.1016\/j.neuropharm.2025.110729_bib39","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2024.116673","article-title":"The interplay between mitochondrial dysfunction and NLRP3 inflammasome in multiple sclerosis: therapeutic implications and animal model studies","volume":"175","author":"Shadab","year":"2024","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.neuropharm.2025.110729_bib40","doi-asserted-by":"crossref","DOI":"10.1016\/j.lfs.2024.123203","article-title":"Bay 11-7082 mitigates oxidative stress and mitochondrial dysfunction via NLRP3 inhibition in experimental diabetic neuropathy","volume":"359","author":"Sharan","year":"2024","journal-title":"Life Sci."},{"issue":"1","key":"10.1016\/j.neuropharm.2025.110729_bib41","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1007\/s11033-024-09779-w","article-title":"The protective effect of parthenolide in an in vitro model of Parkinson's disease through its regulation of nuclear factor-kappa B and oxidative stress","volume":"51","author":"Shariat Razavi","year":"2024","journal-title":"Mol. Biol. Rep."},{"key":"10.1016\/j.neuropharm.2025.110729_bib42","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2023.115909","article-title":"Parthenolide alleviates cognitive dysfunction and neurotoxicity by regulating AMPK\/GSK3\u03b2 (Ser9)\/Nrf2 signaling pathway","volume":"169","author":"Sun","year":"2023","journal-title":"Biomed. Pharmacother."},{"issue":"2","key":"10.1016\/j.neuropharm.2025.110729_bib43","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1002\/jcc.21334","article-title":"AutoDock Vina: improving the speed and accuracy of docking with a new scoring function, efficient optimization, and multithreading","volume":"31","author":"Trott","year":"2010","journal-title":"J. Comput. Chem."},{"key":"10.1016\/j.neuropharm.2025.110729_bib44","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1007\/BF00355047","article-title":"PRODRG, a program for generating molecular topologies and unique molecular descriptors from coordinates of small molecules","volume":"10","author":"Van Aalten","year":"1996","journal-title":"J. Comput. Aided Mol. Des."},{"issue":"8","key":"10.1016\/j.neuropharm.2025.110729_bib45","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0071835","article-title":"Functional mapping of human dynamin-1-like GTPase domain based on x- ray structure analyses","volume":"8","author":"Wenger","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.neuropharm.2025.110729_bib46","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/j.jnutbio.2017.05.001","article-title":"Isoliquiritigenin reduces oxidative damage and alleviates mitochondrial impairment by SIRT1 activation in experimental diabetic neuropathy","volume":"47","author":"Yerra","year":"2017","journal-title":"J. Nutr. Biochem."},{"key":"10.1016\/j.neuropharm.2025.110729_bib47","doi-asserted-by":"crossref","first-page":"2301","DOI":"10.1007\/s12035-016-9824-3","article-title":"Adenosine monophosphate-activated protein kinase abates hyperglycaemia-induced neuronal injury in experimental models of diabetic neuropathy: effects on mitochondrial biogenesis, autophagy and neuroinflammation","volume":"54","author":"Yerra","year":"2017","journal-title":"Mol. Neurobiol."},{"issue":"7","key":"10.1016\/j.neuropharm.2025.110729_bib48","article-title":"Structural insights into G domain dimerization and pathogenic mutation of OPA1","volume":"219","author":"Yu","year":"2020","journal-title":"JCB (J. Cell Biol.)"},{"key":"10.1016\/j.neuropharm.2025.110729_bib49","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/j.mad.2016.02.003","article-title":"Regulation of SIRT1 in aging: roles in mitochondrial function and biogenesis","volume":"155","author":"Yuan","year":"2016","journal-title":"Mechanisms. ageing. develop."}],"container-title":["Neuropharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S002839082500437X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S002839082500437X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,6,7]],"date-time":"2026-06-07T08:24:59Z","timestamp":1780820699000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S002839082500437X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2]]},"references-count":49,"alternative-id":["S002839082500437X"],"URL":"https:\/\/doi.org\/10.1016\/j.neuropharm.2025.110729","relation":{},"ISSN":["0028-3908"],"issn-type":[{"value":"0028-3908","type":"print"}],"subject":[],"published":{"date-parts":[[2026,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Parthenolide attenuates neuroinflammation by targeting NLRP3 inflammasome & mitochondrial dysfunction in experimental diabetic neuropathy","name":"articletitle","label":"Article Title"},{"value":"Neuropharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.neuropharm.2025.110729","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier Ltd. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"110729"}}